![]() ![]() 14 The COG AALL0031 trial later demonstrated that patients with Ph + ALL treated with. gg/GtbF7PjFollow My Instagram! Get your life back. Dabrafenib plus trametinib, a BRAF/ MEK inhibitor combination therapy, was approved by the EMA in 2019 for resected stage III melanoma with BRAF V600 mutation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |